ENP103: Type 1 Diabetes: Immunotherapies and Early Detection

Recently the Endocrine Society held its 12th annual Type 1 Diabetes Fellows Series program, which combines comprehensive education on type 1 diabetes with career development opportunities to build knowledge, practical skills, and a lasting network of colleagues. For this episode, host Aaron Lohr talks with , medical director of the Diabetes Institute and director of the Clinical Research Center at the University of Florida. Dr. Schatz gave a talk at the fellows series program titled, “Immunotherapies for Type 1 Diabetes: Need for Early Detection and Screening.” This year’s fellows series program and this episode were made possible by the support of Abbott Diabetes Care, CeQur Corp., Dexcom Inc., Insulet Corp., Breakthrough T1D (formerly the Juvenile Diabetes Research Foundation), Lilly USA, Mankind Pharma Limited, Medtronic Inc., Novo Nordisk Inc., and Vertex Pharmaceuticals Inc. Show notes are available at — for helpful links or to hear more podcast episodes, visit

You can listen to ENP103: Type 1 Diabetes: Immunotherapies and Early Detection online on Radio and Podcast. Open the player on this page to stream the available audio.

ENP103: Type 1 Diabetes: Immunotherapies and Early Detection is an episode from Endocrine News Podcast by Endocrine Society.

This episode is 23:20 long.

This episode was published on Oct 1, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Endocrine News Podcast when more episodes are available from the podcast feed.